ロード中...
Brain proteomic changes by histone deacetylase inhibition after traumatic brain injury
BACKGROUND: Traumatic brain injury (TBI) is a leading cause of morbidity and mortality. There are currently no cytoprotective treatments for TBI. There is growing evidence that the histone deacetylase inhibitor valproic acid (VPA) may be beneficial in the treatment of TBI associated with hemorrhagic...
保存先:
| 出版年: | Trauma Surg Acute Care Open |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7993337/ https://ncbi.nlm.nih.gov/pubmed/33880414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/tsaco-2021-000682 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|